NIKKEI 225
27,402.05 +55.17 (+0.20%) HANG SENG
21,958.36 -113.82 (-0.52%) CRUDE OIL
76.76 +0.35 (+0.46%) GOLD FUTURES
1,930.30 -12.50 (-0.64%) DOW
34,074.97 -17.99 (-0.05%) BTC-GBP
19,651.07 +718.54 (+3.80%)
Stratec SE (0RAR.L)
| Previous close | 85.20 |
| Open | 87.00 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 86.29 - 88.60 |
| 52-week range | 86.29 - 88.60 |
| Volume | |
| Avg. volume | N/A |
| Market cap | 10.504M |
| Beta (5Y monthly) | 0.30 |
| PE ratio (TTM) | 0.27 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- EQS Group
STRATEC TO PARTICIPATE IN THE 41ST ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
EQS-News: STRATEC SE / Key word(s): ConferenceSTRATEC TO PARTICIPATE IN THE 41ST ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE 15.12.2022 / 15:34 CET/CESTThe issuer is solely responsible for the content of this announcement.STRATEC TO PARTICIPATE IN THE 41ST ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE Birkenfeld, December 15, 2022STRATEC SE, Birkenfeld, Germany, (Frankfurt: SBS; Prime Standard, SDAX) will participate in the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, at
- EQS Group
NEW APPOINTMENT TO BOARD OF MANAGEMENT OF STRATEC SE
EQS-News: STRATEC SE / Key word(s): PersonnelNEW APPOINTMENT TO BOARD OF MANAGEMENT OF STRATEC SE 01.12.2022 / 16:14 CET/CESTThe issuer is solely responsible for the content of this announcement.NEW APPOINTMENT TO BOARD OF MANAGEMENT OF STRATEC SE Birkenfeld, December 1, 2022The Supervisory Board of STRATEC SE, Birkenfeld, Germany, (Frankfurt: SBS; Prime Standard, SDAX) has decided to extend the company’s Board of Management with a further member and appointed Dr. Georg Bauer to the Board with r
- EQS Group
STRATEC REPORTS RESULTS FOR FIRST NINE MONTHS OF 2022
EQS-News: STRATEC SE / Key word(s): Quarter Results/ForecastSTRATEC REPORTS RESULTS FOR FIRST NINE MONTHS OF 2022 03.11.2022 / 06:55 CET/CESTThe issuer is solely responsible for the content of this announcement.STRATEC REPORTS RESULTS FOR FIRST NINE MONTHS OF 2022 Sales in 9M/2022 -7.9% to € 207.7 million (9M/2021: € 225.4 million); constant currency: -11.7% Adjusted EBIT of € 38.1 million in 9M/2022 (9M/2021: € 48.7 million) Adjusted EBIT margin of 18.3% (9M/2021: 21.6%) at upper end of target
